After South Africa announced the breakout of a new and alarming version of the virus last week, researchers started to work immediately away. However, many teams of researchers had already reproduced and mapped the genetic mutations that had created Omicron, the new bad actor in the coronavirus family, by the time the WHO dubbed the new coronavirus lineage Omicron after the Durban facilities.

Omicron’s True Lethality Won’t Be Known For Weeks

As a result, scientists weren’t sure whether Omicron differed considerably from earlier variants, notably Delta, despite many of those alterations being seen in previous versions. If Omicron has obtained any new talents as a consequence of these modifications, it will take weeks of testing to find out for sure

Omicron's True Lethality Won't Be Known For Weeks

Studying what’s going on in the real world, researchers will test samples taken from patients, determine whether Omicron causes the sickness, and keep track of how many samples test positive for Omicron over time.

It is also being investigated whether persons who have been fully vaccinated are more susceptible to Omicron infections than those who have not been fully immunized.

This kind of in-person evaluation might take weeks or even months to complete. According to a company representative on Friday, the new viral variation has already been detected in Botswana and Eswatini, and AstraZeneca is currently researching these countries to gather real-world data on Vaxzevria’s efficiency against it.

Experts have turned to a common pandemic technique: collecting blood samples from vaccinated volunteers and those who have recovered from previous illnesses and combining them with the novel variety or a lab-engineered version known as a pseudovirus to study how immune cells and proteins respond to it.

The bulk of the immune system’s job is done by B cells and T cells, which may be found in blood serum. Similar experiments will be conducted by Pfizer and its BioNTech partner, Moderna, and Johnson & Johnson in the future.

A statement from Johnson & Johnson on Monday said that the company is analyzing blood serum from participants in completed and ongoing booster studies to determine whether it can neutralize the Omicron variant of the virus.

To begin with, this method was used to demonstrate that vaccines were likely to protect people from infection, then to demonstrate that vaccines worked to protect the people against all the Alpha, Beta, Gamma, Delta variants, and finally to offer the 1st evidence of the waning immunity to the vaccines themselves.

Vaccination authorizations, approvals, and usage instructions are all built on this type of laboratory-dish methodology and real-world data. In addition, they will be used to disseminate the word about the risks of Omicron across the world. Experiments in the lab are one option.

An Omicron isolate must be grown in the lab and mixed with serum from people who have been vaccinated before testing can be performed to see whether the vaccinated serum retains antiviral characteristics. The virus matures in a concise amount of time. Honestly, there’s nothing we can do about the time frame.